ALX Oncology Announces Encouraging Final Results from Phase 1 Trial Evaluating Evorpacept in Combination with Standard-of-Care Treatment in Patients with B-cell Non-Hodgkin Lymphoma
ALX Oncology Announces Encouraging Final Results from P…
10 months ago
globenewswire.com
ALX Oncology Announces Encouraging Final Results from Phase 1 Trial Evaluating Evorpacept in Combination with Standard-of-Care Treatment in Patients with B-cell Non-Hodgkin Lymphoma
ALX Oncology Announces Encouraging Final Results from P…
10 months ago
finanznachrichten.de
ALX Oncology Holdings Inc. Advances Separate Clinical Trials Evaluating Investigational CD47-Inhibitor Evorpacept and Novel EGFR-Targeted Antibody-Drug Conjugate ALX2004
ALX Oncology Holdings Inc. Advances Separate Clinical Trials …
2 months ago
marketscreener.com
ALX Oncology Reports Second Quarter 2025 Financial Results and Provides Corporate Update
ALX Oncology Reports Second Quarter 2025 Financial Results an…
3 months ago
finanznachrichten.de
ALX Oncology Reports Third Quarter 2025 Financial Results and Provides Corporate Update
ALX Oncology Reports Third Quarter 2025 Financial Results an…
4 months ago
finanznachrichten.de
Immuno-oncology biotech ALX Oncology prices upsized IPO at $19, above the range
Immuno-oncology biotech ALX Oncology prices upsized IPO at $1…
Jul 17, 2020
nasdaq.com
Mode of Action video for Biotech ALX Oncology - Life Science Animation
2:28
Mode of Action video for Biotech ALX Oncology - Life Science Anim…
1.2K viewsMar 27, 2023
YouTubeLife Science Animation
ALX Oncology | LinkedIn
Jan 13, 2025
linkedin.com
0:38
Watch this step-by-step guide and learn what you need for a smooth …
284 viewsAug 20, 2024
FacebookALX
45:16
080 - Trillium Therapeutics vs. ALX Oncology? The CD47 Space Race…
4K viewsDec 23, 2020
YouTubeBreaking Biotech
深度解析 ALK 肺癌標靶臨床試驗 ALEX：PFS 為史上最高？ OS 大預 …
May 27, 2020
geneonline.news
Transcript : ALX Oncology Holdings Inc., Q3 2025 Earnings Call, Nov 0…
4 months ago
zonebourse.com
3:26
Evolving Options in First Line Treatment of ALK Positive Non S…
200 viewsJun 28, 2017
YouTubeGlobal Resource for Advancing Cancer Education
0:57
Dr. Rotow on Updated ALEX Trial Results in ALK+ NSCLC
190 viewsJan 18, 2020
YouTubeOncLive
36:14
ALX Oncology (ALXO) @ JPM 2026 第44届摩根大通医疗保健会议
19 views1 month ago
bilibilibili_42520431755
2:41
How to Start Treatment for an EGFR Exon 19 Deletion and an ALK Fusi…
17 views1 month ago
YouTubeGlobal Resource for Advancing Cancer Education
ALX Oncology Holdings Inc. Announces Elimination of Positio…
Mar 5, 2025
marketscreener.com
3:00
ALK Rearrangements Drive Oncogenesis and Define a Targeta…
1 views3 months ago
YouTubeStory Lens
Dr Saxena on the Evolving Utility of Targeted Therapies for ALK NSCL…
11 months ago
onclive.com
5:33
In this latest episode of 'Whole Body Health', Dr. Yusuf (JP) Saleeby intr…
616 viewsMay 29, 2024
FacebookFrontline Covid19 Critical Care Alliance
Targeted Therapy and Oncogene Addiction in Lung Cancer: Unders…
74 viewsNov 11, 2024
vumedi.com
4:31
ALK-Positive NSCLC: ALEX Trial
832 viewsJul 11, 2019
YouTubeOncLive
1:02
Dr. Mok on Overall Survival Data From the ALEX Trial in ALK+ Lun…
623 viewsOct 31, 2019
YouTubeOncLive
6:46
Emerging Trends and Combination Therapies for ALK+ NSCLC
65 viewsJul 12, 2019
YouTubeOncLive
47:15
Ms Roxanne Chen - Understanding anaplastic lymphoma kinase (ALK…
472 views5 months ago
YouTubeALKPositive Experts
5:50
ALK-Rearranged & MET Exon 14 NSCLC Treatment Options
249 viewsJun 3, 2020
YouTubeOncLive
8:11
Targeted Therapy for ALK+ NSCLC
40 viewsJul 31, 2019
YouTubeTargeted Oncology
ALK Non-Small Cell Lung Cancer Patient Video: Anne Marie
Sep 2, 2017
novartis.com
4:04
Management of Adverse Events for ALK-Targeted TKIs
33 viewsAug 22, 2019
YouTubeTargeted Oncology
57:37
First-Line Therapy for Metastatic Non-Small Cell Lung Cancer and a…
295 views11 months ago
YouTubeResearch To Practice
See more videos
Static thumbnail place holder